Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006390
Status:
COMPLETED
Last Update Posted:
2023-06-22
First Post:
2000-10-04
Brief Title:
Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Eastern Cooperative Oncology Group
Organization Data
Organization:
Eastern Cooperative Oncology Group
Class:
NETWORK
Study ID:
CDR0000068272
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eastern Cooperative Oncology Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Group Chair
Old Organization:
Eastern Cooperative Oncology Group
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |